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Abstract: Flavin-dependent monooxygenases and
oxidases play an important role in the mineralization
of phenolic compounds. Because of their exquisite
regioselectivity and stereoselectivity, these enzymes
are of interest for the biocatalytic production of fine
chemicals and food ingredients. In our group, we have
characterized several flavoenzymes that act on
phenolic compounds, including 4-hydroxybenzoate
3-hydroxylase, 3-hydroxyphenylacetate 6-hydroxy-
lase, 4-hydroxybenzoate 1-hydroxylase (decarboxy-
lating), hydroquinone hydroxylase, 2-hydroxybiphen-
yl 3-monooxygenase, phenol hydroxylase, 4-hydroxy-
acetophenone monooxygenase and vanillyl-alcohol
oxidase. The catalytic properties of these enzymes are
reviewed here, together with insights obtained from
site-directed and random mutagenesis.
1 Introduction
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1 Introduction
Phenolic compounds constitute one of the largest
groups of natural products. Being synthesized by
plants, their microbial degradation forms a substantial
part of the biogeochemical cycle. Besides natural
phenols, many anthropogenic (halo)phenolic deriva-
tives are found in soil. These compounds have been used
as building blocks in chemical and pharmaceutical
syntheses and as herbicides and pesticides, sometimes
causing serious local contamination of the environment.
The mineralization of (halo)phenolic compounds by
aerobic microorganisms is initiated by the action of
inducible flavoenzymes. These include flavoprotein
monooxygenases, which use electrons from NAD(P)H
to activate and cleave a molecule of oxygen, enabling
incorporation of an oxygen atom into the substrate, as
well as flavoprotein oxidases which react with their
substrates without the need of external cofactors using
only molecular oxygen.
Flavoprotein monooxygenases that are active with
phenolic compounds usually contain FAD as prosthetic
group. They activate molecular oxygen through the
formation of a reactive flavin (hydro)peroxide which
can attack the substrate by an electrophilic or nucleo-
philic process depending on the protonation state of the
flavin (hydro)peroxide and the nature and protonation
state of the substrate. In aromatic hydroxylation
reactions, the flavin hydroperoxide acts as an elec-
trophile. However, in Baeyer±Villiger monooxy-
genation reactions, the flavin peroxide is active as a
nucleophile.[1]
Flavoprotein monooxygenases are of interest for
biocatalytic applications, since they are able to perform
regioselective and stereoselective oxidations undermild
and environmentally friendly conditions.[2] Aspects
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relevant for biotechnological application of flavopro-
tein monooxygenases are the substrate and cofactor
specificity, the regioselectivity and stereoselectivity of
the conversions and the efficiency of the reactions
including chances of unwanted side reactions and
products. Clearly, these important characteristics are
highly dependent on the structure-activity character-
istics dictated by the active site of the enzymes. So far,
relatively little is known about the structure-function
relationship of flavoprotein monooxygenases. Except
for p-hydroxybenzoate hydroxylase (PHBH) from
Pseudomonas fluorescens[3] and phenol hydroxylase
from Trichosporon cutaneum,[4] no structural informa-
tion is available at the atomic level. Furthermore, with
the aromatic hydroxylases of known structure it is
unclear how the protein interacts with the pyridine
nucleotide coenzyme.[5,6]
Based on sequence homology, FAD-dependent mono-
oxygenases belong to the following subclasses:[1,7]
i) Aromatic hydroxylases. These enzymes share a
typical dinucleotide binding domain for FAD binding,
but lack a commonNAD(P) binding fold.[8] PHBH is the
prototype of this subclass.
ii) Baeyer±Villiger monooxygenases and N-hy-
droxylating enzymes. Many of these flavoproteins, like
cyclohexanone monooxygenase and dimethylaniline
monooxygenase, contain two dinucleotide binding
motifs (-folds), one for FAD binding and one for
NAD(P) binding.[9]
There are also aromatic hydroxylases that use FADor
FMN only as a coenzyme. With these enzymes, the
reduced flavin is supplied by a flavin reductase at the
expense of NAD(P)H. The protein partners of these
aromatic hydroxylases do not tightly interact and
contain no common dinucleotide binding motifs. Rep-
resentatives of these two-component aromatic hy-
droxylases are pyrrole-2-carboxylate monooxyge-
nase[10] and 4-hydroxyphenylacetate 3-hydroxylase.[11]
In addition to flavoprotein monooxygenases, also
flavoprotein oxidases forman important groupof flavin-
dependent biocatalysts. Flavoprotein oxidases are
attractive for synthetic applications because they con-
stitute a group of enzymes that use molecular oxygen as
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a clean and cheap oxidant and do not require expensive
cofactors. The best characterized flavoprotein oxidase
which acts on phenolic compounds is vanillyl-alcohol
oxidase (VAO).[12] Unlike other flavoprotein oxidases
such as glucose oxidase and -amino acid oxidase,[13,14]
VAO is structurally not related to the flavoprotein
aromatic hydroxylases.[15]
In this reviewwe discuss the different classes of flavin-
dependent monooxygenases and oxidases that are
active with phenolic compounds. For each class, a
model enzyme is discussed to illustrate the catalytic
potential as well as the limits and opportunities defined
by their active site characteristics and mechanism of
catalysis. For the flavoprotein aromatic hydroxylases,
which form the largest subclass of flavin-dependent
monooxygenases, a few other family members are
discussed as well.
2 Flavoprotein Aromatic Hydroxylases
Flavoprotein aromatic hydroxylases have many cata-
lytic properties in common and their substrate specific-
ity is consistent with an electrophilic aromatic substitu-
tion mechanism.[1] To illustrate the mechanism of action
of flavoprotein aromatic hydroxylases and their cata-
lytic potential and limitations, we start this reviewwith a
detailed overview of the properties of PHBH from
P. fluorescens. This enzyme is the most well-studied
member of this class of flavoenzymes and its catalytic
mechanism is representative for the whole family.
2.1 4-Hydroxybenzoate 3-Hydroxylase
PHBH from P. fluorescens is a homodimer of about
88 kDa with each subunit containing a non-covalent-
ly bound FAD.[16] PHBH catalyzes the conversion
of 4-hydroxybenzoate into 3,4-dihydroxybenzoate
(Scheme 1), a common intermediate step in the bio-
degradation of aromatic compounds in soil. The enzyme
from P. fluorescens is strictly NADPH dependent.[17]
However, some PHBH enzymes from other strains
prefer NADH as electron donor.[18,19]
PHBH is one of the first flavoenzymes with known
three-dimensional structure.[20] Figure 1 presents a
ribbon structure of the enzyme-substrate complex as
refined at 1.9 ä resolution.[3] The folding topology of
PHBH is shared by several other oxidative flavoen-
zymes, including cholesterol oxidase,[21] glucose oxi-
dase,[22] -amino acid oxidase,[23] and phenol hydrox-
ylase.[4] Crystal structures have also been obtained of
PHBH in complex with substrate analogues and of a
number ofmutant enzymes.[5,6,24±30] The PHBH structure
can be divided in three domains:[3] the FAD binding
domain (residues 1 ± 175), the substrate binding domain
(residues 176 ± 290), and the interface domain (res-
idues 291 ± 394). However, in recent structural classifi-
cations, the FAD binding domain and interface domain
are regarded as a single domain, leaving PHBHas a two-
domain protein.[13]
The substrate binding site of PHBH is deeply buried in
the protein.[3] Crystallographic studies with substrate
and flavin analogues have indicated that the flavin ring
moves out of the active site to allow substrate binding
and product release.[24,25,27] Figure 2 presents a close up
of the substrate binding site. Arg214 forms an indispen-
sable ionic interaction with the carboxyl group of the
substrate.[31] Ser212 and Tyr222 are also involved in
binding the carboxylic moiety of 4-hydroxybenzoate.
Substrate hydroxylation is facilitated by deprotonation
Scheme 1. Reactions catalyzed by flavoprotein monooxyge-
nases and oxidases described in this review. (A) ortho-
hydroxylation of 4-hydroxybenzoate, (B) para-hydroxylation
of 3-hydroxyphenylacetate, (C) oxidative decarboxylation of
4-hydroxybenzoate, (D) ortho-hydroxylation of hydroqui-
none, (E) ortho-hydroxylation of 2-hydroxybiphenyl, (F)
Baeyer-Villiger oxidation of 4-hydroxyacetophenone, (G)
oxidation of vanillyl-alcohol, (H) VAO-mediated hydroxyla-
tion of eugenol, and (I) VAO-mediated hydroxylation of 4-
ethylphenol.
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of the phenol.[32±35] The hydroxy group of the substrate is
at hydrogen bond distance of Tyr201 which contacts
Tyr385. Selective Phe replacements of these tyrosine
residues strongly hamper substrate deprotonation and
flavin reduction.[36,37] Pro293 is another important active
site residue and is located in a highly conserved loop.
The peptide carbonyl oxygen of Pro293 is within
hydrogen bonding distance of the phenolic oxygen of
bound substrate. It has been inferred from site-directed
mutagenesis that the backbone rigidity at residue 293 is
important for controlling the conformation of the flavin
that is central to coordinating the complexities of
catalysis.[38]
The catalytic mechanism of PHBH has been studied
by stopped-flow absorbance spectroscopy.[39±41] The
overall reaction can be divided into two half reactions,
the reductive half reaction and the oxidative half
reaction, each consisting of several reaction steps
(Scheme 2). The reductive half reaction, which can be
studied under anaerobic conditions, involves ternary
complex formation. Only in the presence of substrate is
fast reduction of the FAD cofactor by NADPH
observed.[17,42] In the absence of substrate, a binary
complex between NADPH and the enzyme results in a
reduction rate that is 105 times slower. Thus, the
substrate is an essential component in the reduction
reaction because it stimulates the rate of flavin
reduction, without being converted itself.
Only a few substrate analogues can stimulate the rate
of flavin reduction.[37,43] Some benzoate derivatives bind
to the enzyme and elicit its reduction but are not
converted, and are therefore called effectors. The
potential substrate 4-aminobenzoate binds to the
enzyme in a similar way as 4-hydroxybenzoate,[24] but
the reduction reaction in the presence of 4-amino-
benzoate is very slow,[39] indicating a fine-tuning of the
mechanism by which the substrate exerts its effector
action. The rate of reduction does not correlate with the
orientation of the flavin ring observed in the crystal
structures, and all evidence presently available suggests
that the effector specificity is linked to the ionic state of
the substrate and the hydrogen bond network connect-
ing the 4-hydroxy group with the protein surface.[24,44]
The fast release of NADP from the reduced ternary
complex is well established.[28,39,40] Furthermore, it has
been demonstrated that the rate of dissociation of the
substrate from the reducedenzyme-substrate complex is
5000 times slower than from thebinary complexwith the
flavin in its oxidized state.[39] In addition to the increased
reduction rate induced by substrate binding, the slow
rate of substrate dissociation from the reduced enzyme
is a secondmechanismbywhich the enzyme controls the
optimal use of valuable reducing equivalents.
The oxidative half reaction includes the reaction steps
that lead to the hydroxylation of the substrate.[39,41]
Upon reaction of the reduced enzyme-substrate com-
plex with molecular oxygen the flavin C(4a)-hydro-
peroxide intermediate is formed. Several authors have
discussed the actual way in which this reaction occurs,
since in principle the reaction between singlet reduced
flavin and triplet molecular oxygen is spin forbidden.[45]
Figure 1. Ribbon diagram of the crystal structure of the
enzyme-substrate complex of p-hydroxybenzoate hydroxy-
lase from Pseudomonas fluorescens.[3] The isoalloxazine ring
of the FAD is located close to the aromatic substrate in the
interior position in the active site. Figure 2. Close-up view of the active site of the enzyme-
substrate complex of p-hydroxybenzoate hydroxylase from
Pseudomonas fluorescens.[3] The FAD is gray, the aromatic
substrate is white, and the protein residues are black. The si
face of the flavin is the back of the page in this view; the re
side is the front, as seen with the substrate phenol pointing
out of the page.
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The flavin C(4a)-hydroperoxide species is generally
referred to as intermediate I and has a typical absorp-
tion spectrum.[39,41] Protonation of the distal oxygen of
the peroxide moiety increases the electrophilic reac-
tivity of the flavin peroxide and facilitates its subsequent
attack on the nucleophilic carbon centre of the
substrate. In the hydroxylation step, the product 3,4-
dihydroxybenzoate is formed together with the flavin
C(4a)-hydroxide (intermediate III). The aromatic prod-
uct initially is formed in its keto isomeric form
(intermediate II)[46,47] which isomerizes to give the
energetically favored dihydroxy isomer. Evidence for
the initial formation of the quinoid form of the aromatic
product comes from experiments with 2,4-dihydroxy-
benzoate as the substrate.[39,41,48]
In PHBH, the electron density on the C3 reaction
centre of the substrate is increased by deprotonation of
the phenol. This is supported by spectroscopic binding
studies,[32,33,49] by molecular orbital calculations on the
reactivity of the substrate,[34] and by reaction pathway
calculations.[35] Moreover, the role of Tyr201 and Tyr385
in substrate activation is well established.[50]
In the presence of non-substrate effectors, the flavin
C(4a)-hydroperoxide decays to oxidized enzyme with
release of hydrogen peroxide.[43] Uncoupling can also
occur with true substrates. The extent to which this
uncoupling occurs is not only dependent on the nature
and possibilities for activation of the substrate but is also
influenced by the microenvironment of the active site.
Other flavin-dependent monooxygenases as well as
mutant PHBH enzymes may vary in the efficiency of
substrate hydroxylation.[50]
The final steps in the catalytic cycle are the elimina-
tion of water from the flavin C(4a)-hydroxide and
product release. Studies with 2-fluoro-4-hydroxyben-
zoate[51] and with the related phenol hydroxylase[47,52]
have indicated that in this step a dead-end complex can
be formed between the flavin C(4a)-hydroxide form of
the enzyme and the substrate leading to substrate
inhibition.
Studies from active-site variants have revealed that
the scope of reactions catalyzed by PHBH cannot easily
be changed by site-directed mutagenesis. Nevertheless,
replacement of Tyr385 by Phe affects the regiospecific-
ity of hydroxylation[36] and turns the enzyme into amore
efficient dehalogenase.[53] Studies with tetrafluoro-4-
hydroxybenzoate revealed that the hydroxylation of this
fluorinated substrate is not restricted to the C3 centre of
the aromatic ring but rather involves sequential oxy-
genation steps. 19F NMR analysis showed that the initial
aromatic product 2,5,6-trifluoro-3,4-dihydroxybenzoate
is further converted to 5,6-difluoro-2,3,4-trihydroxy-
benzoate and that this reaction is most efficient with
mutant Y385F. The initial dihydroxy product is not
bound in a unique regiospecific orientation as also 2,6-
difluoro-3,4,5-trihydroxybenzoate is formed. Due to
elimination of the halogen substituent as a fluoride
anion and the electron balance of the reaction, hydrox-
Scheme 2. Catalytic cycle of flavoprotein aromatic hydroxylases.[39±41] EFlOXS, oxidized enzyme-substrate complex; EFlredS,
reduced enzyme-substrate complex; EFlHOOH-S, flavin C(4a)-hydroperoxide enzyme-substrate complex (intermediate I);
EFlHOH-P*, flavin C(4a)-hydroxide enzyme-hydroxycyclohexadienone product complex (intermediate II); EFlHOH-P, flavin
C(4a)-hydroxide enzyme-product complex (intermediate III), S, substrate; P, product.
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ylation of tetrafluoro-4-hydroxybenzoate involves the
formation of quinone intermediates as primary products
of oxygenolytic dehalogenation.[51] Ascorbate competes
favorably with NADPH for the non-enzymatic reduc-
tion of these reactive intermediates and prevents the
accumulation of non-specific oxidation products.[53]
PHBH does not contain a common dinucleotide fold
for NADPH binding.[8] Studies from site-directed
PHBH mutants have provided some insight into the
mode of coenzyme recognition. Based on the properties
of His162 and Arg269 variants, an interdomain binding
mode for NADPH was proposed, where His162 and
Arg269 interact with the pyrophosphate moiety of
NADPH.[5] Furthermore, by changing several amino
acid residues in the solvent exposed helix H2 region, it
was possible to switch the PHBH coenzyme specific-
ity.[54] This is the first coenzyme reversion of amember of
a superfamily of flavoenzymes where the exact binding
mode of the cofactor is unknown. The coenzyme switch
suggests that in PHBH, an arginine is important in the
recognition of the 2-phosphate moiety of NADPH and
that an acidic group (Asp/Glu) is required for the
recognition of the 2-OH group of NADH. This
strengthens the idea that in NAD(P)H-dependent
enzymes the main determinants for coenzyme recog-
nition are conserved[55] and is in keeping with the
hypothesis that biological specificity is caused to some
extent by hydrogen bonding but is best mediated by
charged residues.[56]
Recently, the first crystal structure of PHBH with
NADPHwas obtained.[6] In this structure of the R220Q
mutant, theNADPHbinds in anextended conformation
at the enzyme surface in a groove that crosses the
binding site of FAD. The pyrophosphate moiety is
indeed situated in between the FAD binding domain
and substrate binding domain but especially the
nicotinamide moiety is located in a region not expected
to be relevant for catalysis. Therefore, a role was
proposed for protein and ligand dynamics with multiple
movements involving the protein, the two cofactors, and
the substrate.[6] However, the R220Q mutation changes
the interdomain interaction, possibly influencing the
mode of NADPH binding.
In conclusion, PHBH is an enzyme with a rather
narrow substrate specificity. Besides the natural sub-
strate (Scheme 1), the enzyme can convert 2,4-dihy-
droxybenzoate and a series of fluorinated 4-hydroxy-
benzoates. Most substrates are regioselectively hy-
droxylated at the C3-postion of the aromatic ring.
With some substrate analogues and certain mutant
enzymes, hydroxylation at C2 and C5 is feasible as well.
2.2 3-Hydroxyphenylacetate 6-Hydroxylase
3-Hydroxyphenylacetate 6-hydroxylase (HPAH) is an
NAD(P)H-dependent FAD-containing monooxyge-
nase involved in the catabolism of phenylacetate in
Flavobacterium sp. JS-7.[57] The enzyme has a subunit
mass of 63 kDa and exists mainly as a homodimer in
solution. HPAH from Flavobacterium is optimally
active around pH 8.3 but is most stable around pH 7.0.
AbovepH 7.5, the enzymeeasily loosesFADandduring
purification, the presence of FAD and dithiothreitol are
needed for high recovery of enzyme activity. Like many
other flavoprotein monooxygenases, HPAH is severely
inhibited by chloride ions, competitive to the aromatic
substrate.
HPAH has a narrow substrate specificity. Besides 3-
hydroxyphenylacetate which is stoichiometrically con-
verted to 2,5-dihydroxyphenylacetate (Scheme 1), the
only alternative substrate is 3,4-dihydroxyphenylace-
tate. This compound is exclusively converted to the (red)
quinoid form of 2,4,5-trihydroxyphenylacetate. Due to
severe uncoupling of hydroxylation (formation of
hydrogen peroxide), more than two equivalents of
NAD(P)H are needed for the conversion of one
equivalent of 3,4-dihydroxyphenylacetate. Therefore, a
catalase and glucose-6-phosphate containing NADPH
generating system[58] is recommended to generate this
product at a large scale.
2.3 4-Hydroxybenzoate 1-Hydroxylase
4-Hydroxybenzoate 1-hydroxylase from Candida para-
psilosis CBS604 is a monomeric FAD-dependent
monooxygenase of about 50 kDa.[59] This enzyme is
induced when the yeast is grown on either 4-hydroxy-
benzoate, 2,4-dihydroxybenzoate, or 3,4-dihydroxyben-
zoate as the sole carbon source.[60] 4-Hydroxybenzoate
1-hydroxylase is optimally active at pH 8.0 and catalyzes
the oxidative decarboxylation of a wide range of 4-
hydroxybenzoate derivatives to the corresponding
hydroquinones with the stoichiometric consumption of
NAD(P)H and oxygen (Scheme 1).[61] Interestingly,
nearly no hydroxylation activity is observed with 4-
aminobenzoates. 4-Hydroxybenzoate 1-hydroxylase
prefers NADH as the electron donor and is inhibited
by chloride ions and by 3,5-dichloro-4-hydroxyben-
zoate, 4-hydroxy-3,5-dinitrobenzoate, and 4-hydroxy-
isophthalate which are competitors with the aromatic
substrate. From the high activity of 4-hydroxybenzoate
1-hydroxylase with tetrafluoro-4-hydroxybenzoate and
4-hydroxy-3-nitrobenzoate and the molecular orbital
characteristics of 4-hydroxybenzoate derivatives it was
inferred that the phenolate form of the substrates is
important for catalysis and that substrate hydroxylation
involves the electrophilic attack of the putative flavin
hydroperoxide at the C1-atom of the aromatic ring.[61]
The resulting benzoquinone species is subsequently
converted to the hydroquinone by spontaneous release
of the carboxyl side chain.[61]
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2.4 Hydroquinone Hydroxylase
Hydroquinone hydroxylase is a homodimeric FAD-
dependent monooxygenase of about 150 kDa, which is
also involved in the degradation of 4-hydroxybenzoate
in Candida parapsilosis CBS604.[62] This enzyme is
abundantly expressed when the yeast is grown on
either 4-hydroxybenzoate, 2,4-dihydroxybenzoate, 1,3-
dihydroxybenzene, or 1,4-dihydroxybenzene as sole
carbon source. Hydroquinone hydroxylase catalyzes
the ortho-hydroxylation of a wide range of monocyclic
phenols with the stoichiometric consumption of
NADPH and oxygen (Scheme 1). The hydroxylation
of monofluorinated phenols is highly regiospecific with
a preference for C6 hydroxylation. This regiospecificity
of hydroxylation resembles that of phenol hydroxylase
fromT. cutaneum,[63] but differs from the regiochemistry
experienced with whole cells of the Gram-positive
bacterium Rhodococcus opacus 1G, where it was found
that oxidative dehalogenation of 2-halogenated phenols
is preferred to hydroxylation of the aromatic ring at a
non-halogenated position.[64] It also differs from the
transformation of monofluorophenols in whole cells of
R. opacus 1cp, where it was found that the initially
formed catechols are further converted to the corre-
sponding fluoropyrogallols.[65]
During purification it was noted that hydroquinone
hydroxylase is sensitive to limited proteolysis.[62] Pro-
teolytic cleavage does not influence the enzyme×s
dimeric nature but results in relatively stable protein
fragments of 55, 43, 35 and 22 kDa. N-Terminal peptide
sequence analysis revealed the presenceof twonick sites
and showed that hydroquinone hydroxylase from
C. parapsilosis is structurally related to phenol hydrox-
ylase from T. cutaneum. The latter enzyme has been
overexpressed in E. coli[66] and its three-dimensional
structure was recently solved.[4] From the crystallo-
graphic data it was argued that the severe uncoupling of
hydroxylation in phenol hydroxylase is related to a
movement of the flavin ring in concert with a large
conformational change of a flexible protein segment
which acts as an active site lid. The C-terminal part of
this flexible segment is closest to the flavin and its amino
acid sequence is not conserved in hydroquinone
hydroxylase from C. parapsilosis.[62] This suggests that
the efficient hydroxylation of phenolic substrates in
hydroquinone hydroxylase from C. parapsilosis is re-
lated to the performance of the active site lid and that an
effective closure of this lid sequesters the hydroxylation
site from solvent, thereby preventing the unproductive
formation of hydrogen peroxide.
2.5 2-Hydroxybiphenyl 3-Monooxygenase
2-Hydroxybiphenyl 3-monooxygenase (HbpA) is an
inducible FAD-dependent aromatic hydroxylase in-
volved in the degradation of the fungicide 2-hydroxybi-
phenyl by the soil bacterium Pseudomonas azelaica
HBP1[67]. This strain employs a meta-cleavage pathway
with a broad substrate spectrum for breaking down 2-
hydroxybiphenyls.[68] HbpA is a homotetramer of about
250 kDa, is optimally active around pH 7.5 and prefers
NADH as the electron donor. 2,3-Dihydroxybiphenyl,
the product of the reaction with 2-hydroxybiphenyl
(Scheme 1) is a non-substrate effector, strongly facili-
tating NADH oxidation and hydrogen peroxide forma-
tion without being hydroxylated.
HbpA catalyzes the ortho-hydroxylation of a wide
range of 2-substituted phenols. Besides phenyl rings and
aliphatic side chains, halogens are accepted as phenol
substituents.[69] The hbpA gene has been cloned in
E. coli[67] and the recombinant strainwas used as awhole
cell biocatalyst for the large-scale production of 2-
substituted catechols.[70] Thewhole cell approach has the
advantage of coenzyme recycling but can be problem-
atic when the substrate and/or product are toxic to the
cells. In case of HbpA, the toxic effects of 2-hydroxy-
biphenyl are minimized by feeding the substrate to the
reactor at a rate slightly below the maximum biooxida-
tion rate. Furthermore, the 3-phenylcatechol product
can be removed by continuous adsorption on a solid
resin.[70] In another biocatalytic process, partially puri-
fied recombinant HbpAwas used in combination with a
formate/formate dehydrogenase cofactor recycling
system for the preparative regioselective hydroxylation
of 2-hydroxybiphenyl.[71] By using organic/aqueous
emulsions, coupled with in situ product recovery,
volumetric productivities of up to 0.45 g L1 h1 were
obtained.
The catalytic mechanism of HbpA has been inves-
tigated at 7 C by stopped-flow absorption spectrosco-
py.[72] The reaction essentially follows the catalytic cycle
depicted in Scheme 2. Binding of 2-hydroxybiphenyl
highly stimulates the rate of enzyme reduction by
NADH. During this reaction a transient charge-trans-
fer complex is formed between the reduced flavin and
NAD. Free reduced HbpA reacts rapidly with oxygen
to form oxidized enzyme with no appearance of
intermediates. In the presence of 2-hydroxybiphenyl
(but not in the presence of 3-phenylcatechol), two
consecutive spectral intermediates are observed, repre-
senting the flavin C(4a)-hydroperoxide and the flavin
C(4a)-hydroxide, respectively. These data are consistent
with a ternary complex mechanism in which the
aromatic substrate has strict control in both the
reductive and oxidative half-reaction in a way that
reactions leading to substrate hydroxylation are favored
over those leading to the futile formation of hydrogen
peroxide.
The catalytic scope and performance of HbpA have
been improved by directed evolution using error-prone
PCR.[73] In situ screening of mutant libraries resulted in
the identification of the I244V variant, which has an
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increased activity towards 2-tert-butylphenol, 2-me-
thoxyphenol, and the natural substrate 2-hydroxybi-
phenyl. The double replacement V368A/L417F was
found to improve the efficiency of substrate hydroxyla-
tion by reducing the uncoupled oxidation of NADH.
Sequence alignments revealed that the primary struc-
ture of HbpA shares 20% identity with phenol hydrox-
ylase from T. cutaneum. Based on structure homology
modelling it was inferred that Ile244 of HbpA is located
in the substrate binding pocket and is involved in
accommodating the phenyl substituent of the phenol. In
contrast, Val368 and Leu417 are not close to the active
site and would not have been obvious candidates for
modification by rational design. In another study,
laboratory evolution of HbpA resulted in an enzyme
variant which hydroxylates indole and indole deriva-
tives, such as hydroxyindoles or 5-bromoindole.[74] This
indigo-producingHbpAvariant contains the amino acid
substitutions Asp222Val and Val368Ala. Interestingly,
Asp222 is located in the active site and corresponds to
Tyr201 of PHBH and Tyr289 of phenol hydroxylase
from T. cutaneum. Recent results from site-directed
mutagenesis have indicated that Tyr289 in phenol
hydroxylase is mainly involved in flavin reduction[75]
whereas Tyr201 in PHBH is also involved in substrate
activation.[36,37] In conclusion, these studies show that
directed evolution is a powerful approach for changing
the biocatalytic performance of a flavoenzyme.
2.6 Two-Component Aromatic Hydroxylases
Besides the single-component flavoprotein aromatic
hydroxylases, there is also a group of flavin-dependent
aromatic hydroxylases that consist of two protein
components of different size. For 4-hydroxyphenylace-
tate 3-hydroxylase from Pseudomonas putida it was
shown that the FAD-containing protein component acts
as an NADH oxidase and that the presence of the other
non-redox protein component is required for efficient
substrate hydroxylation.[76] So far, this is the only
example of a flavoprotein hydroxylase where binding
of another protein component is needed for the
stabilization of the flavin hydroperoxide.
Another family of two-component flavin-dependent
aromatic hydroxylases consists of a relatively small
flavin reductase which generates reduced flavin at the
expense of NAD(P)H and a large protein component
which is essential for substrate hydroxylation.[10,11]
Besides hydroxylases, also epoxide-forming enzymes
such as styrene monooxygenase[77] and tryptophan 7-
halogenase[78] belong to this family. The exact mecha-
nism by which the reduced flavin in these enzymes is
transferred to theoxygenation site is as yet far fromclear
but it has been shown that the small reductase from the
wild-type strain can be replaced by a flavin reductase
from another bacterium.[11,78] In our group, we have
characterized a two-component phenol hydroxylase
from the thermophilic bacterium Bacillus thermogluco-
sidasius which is active with a range of simple phenols,
including chlorophenols, fluorophenols, and cresols.[79]
The large dimeric protein component of the recombi-
nant phenol hydroxylase as expressed inE. coli is highly
unstable in purified form, limiting structure-function
relationship studies. The small dimeric flavin reductase
on the other hand, is very stable in its recombinant form.
Interestingly, each subunit of the reductase contains a
tightly bound FAD molecule which is involved in the
NADH-dependent reduction of free flavins, including
FAD, FMN, and riboflavin.[80] However, like tryptophan
7-halogenase,[78] the large oxygenase component of
phenol hydroxylase from B. thermoglucosidasius is
specific for FAD.
3 Baeyer±Villiger Monooxygenases
Baeyer±Villiger monooxygenases (BVMOs) are
NAD(P)H-dependent flavoenzymes that catalyze
Baeyer±Villiger reactions, i.e., the oxidation of ketones
to esters or lactones.[81,82] In the enzymatic Baeyer±
Villiger reaction, the protein-bound flavin peroxide is
active in its deprotonated form thereby performing a
nucleophilic attack on the carbon atom of the substrate
ketone.[83,84] From rapid reaction studies on Acineto-
bacter cyclohexanone monooxygenase, evidence was
obtained that the relatively stable flavin peroxide can
undergo acid/base equilibrium.[85] This might explain
why BVMOs are also active with certain electron-rich
compounds[82] and underlines the ambivalent character
of the flavin (hydro)peroxide oxygenation species.
BVMOs are versatile biocatalysts that have been
widely used for the regio- and stereoselective trans-
formation of aliphatic ketones.[82,86,87] In view of the need
of NAD(P)H-recycling, most of these reactions have
been performed with whole microbial cells.[88] Relative-
ly little is known about BVMOs that are active with
aromatic compounds. However, several aerobic micro-
organisms are capable of utilizing aryl ketones for their
growth[89] and recently, we succeeded in the purification
of aBaeyer±Villiger type flavoenzyme that catalyzes the
first step in the degradation of 4-hydroxyacetophenone
in Pseudomonas fluorescens ACB.[7,90] Characterization
revealed that this 4-hydroxyacetophenone monooxyge-
nase (HAPMO) is a homodimer of about 140 kDa with
each subunit containing a tightly non-covalently bound
FAD. In contrast, HAPMO involved in the degradation
of 4-ethylphenol in P. putida JD1 purifies as a monomer
of 70 kDa.[89]
HAPMO from P. fluorescens catalyzes the strictly
NADPH-dependent and stoichiometric oxidation of 4-
hydroxyacetophenone to 4-hydroxyphenyl acetate
(Scheme 1). Besides the natural substrate, HAPMO is
active with a wide range of other aryl ketones.[7] The
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highest catalytic efficiency is observed with compounds
bearing an electron-donating substituent at the para-
position of the aromatic ring. HAPMO is also active
with 4-hydroxybenzaldehyde and 4-hydroxypropiophe-
none.
Ring-substituted phenyl acetates are valuable syn-
thons for the production of fine chemicals and neuro-
active pharmaceuticals.[91] However, the large-scale
production of phenyl acetates by whole cells of
P. fluoresensACB is limited by the presence of a highly
active esterase.[90,92] 19F NMR studies with purified
HAPMO at pH 6 and pH 8 showed that the Baeyer±
Villiger oxidation of 4-fluoroacetophenones occurs
faster at pH 8 but that the fluorophenyl acetates
produced are better stabilized at pH 6.[90] Thus, the
large-scale biocatalytic production of ring-substituted
phenyl acetates requires carefully selected conditions
and should either be performed by i) using an
engineered microbial strain that lacks esterase activity
or ii) by using isolated enzyme coupled with an efficient
cofactor recycling system.[93]
With the above considerations in mind, the DNA of
P. fluorescensACB was isolated and the operon encod-
ing genes involved in the degradation of 4-hydroxyace-
tophenone were characterized.[7] The fourth gene of this
operon (hapD) encodes for 4-hydroxyphenyl acetate
hydrolase whereas the fifth gene (hapE) encodes for
HAPMO. Sequence analysis revealed that except for an
N-terminal extension of about 135 residues, HAPMO
shares 30% sequence identity with two other charac-
terized BVMOs, cyclohexanone monooxygenase and
steroid monooxygenase, classifying the enzyme as a
type I BVMO. These BVMOs are FAD and NADPH
dependent and have identical subunits. Type II BVMOs
on the other hand are FMN and NADH dependent and
are composed of 2 trimers.[86] The role of the N-
terminal extension in HAPMO is not clear, but studies
of truncated forms indicate that the N-terminal domain
is important for the protein structural integrity.[7]
Type I BVMOs contain two dinucleotide binding
motifs (-folds), one for FAD binding and one for
NAD(P) binding. Because no crystal structures of these
flavoenzymes are available yet, it was of interest to
probe the functional role of these sequence motifs in
further detail. Using newly reported BVMO sequences,
a BVMO identifying-sequence motif: FxGxxxHxxx-
W(P/D) was uncovered that is critically involved in
catalysis.[9] The important role of the histidine in this
fingerprint sequence was confirmed by the negligible
activity of the H296A mutant. The functional role of
another sequence motif was assessed by replacement of
the conserved Gly490.[7] Analysis of the G490A mutant
revealed a dramatic effect on the interaction with
NADPH, suggesting that the ATG motif comprising
Gly490 is involved in NADPH binding.
4 Flavoprotein Oxidases
Flavoprotein oxidases react with their substrates with-
out theneedof external cofactors.Catalysis involves two
half-reactions in which first the flavin cofactor is
reduced by the substrate, and subsequently the reduced
flavin is reoxidized by molecular oxygen.[1] Vanillyl-
alcohol oxidase (VAO) from Penicillium simplicissi-
mum is the prototype flavoprotein oxidase that is active
with phenolic compounds. VAO is a homooctamer of
520 kDa with each subunit containing a covalently
bound 8-(N3-histidyl)-FAD.[94] VAO catalyzes the
conversion of vanillyl alcohol to vanillin in the presence
of molecular oxygen (Scheme 1). Besides vanillyl
alcohol, the enzyme is active with a wide range of
other phenolic compounds.[95,96] As discussed else-
where,[97] some of the VAO-mediated reactions are of
industrial relevance.
Stopped-flowkinetic studies[98] have indicated that the
reaction of VAO with phenolic substrates involves the
initial transfer of a hydride from the C-atom of the
substrate to the N5-atom of the flavin, resulting in the
formation of a complex between reduced enzyme and p-
quinone methide product intermediate. Next, the
reduced flavin is reoxidized by molecular oxygen,
yielding hydrogen peroxide, and the p-quinone me-
thide intermediate is further converted by water in the
enzyme active site. With eugenol as a substrate, this
leads to the stoichiometric formation of coniferyl
alcohol (Scheme 1), whereas with 4-ethylphenol, the
hydroxy group becomes exclusively inserted at the C-
atom, resulting in the formation of 1-(4-hydroxphen-
yl)ethanol (Scheme 1).With short-chain 4-alkylphenols,
the protein-bound quinonemethide is attacked bywater
in a stereospecific manner yielding the (R)-enantiomer
of the alcohol product in high enantiomeric excess.[99]
However, with long-chain 4-alkylphenols, the p-qui-
none methide is no longer attacked by water and
rearranges to the alkene.[96] A similar observation was
made when the reaction with 4-propylphenol was
performed in organic solvents,[100] leading to the
conclusion that the outcome of products formed from
short-chain and medium-chain 4-alkylphenols is due to
variations in the intrinsic reactivity of the enzyme-
bound p-quinone methide, the water accessibility of the
enzyme active site, and the orientation of the alkyl side-
chain of the substrate.No catalytic activity was observed
with 4-alkylphenols when the aliphatic side-chain is
longer than seven carbon atoms.[96] This is in line with
structural data which show that the VAO active site
cavity is completely filled when the inhibitor 1-(4-
heptenyl)phenol is bound.[101]
From the VAO structure,[101] several amino acid
residues have been implicated to play an important
role in catalysis. Studies fromHis61 andHis422mutants
established that the covalent linkage between the C8
atom of the isoalloxazine ring of the flavin and the N3
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atom of His422 raises the redox potential of the FAD
cofactor, thereby increasing the oxidative power of the
enzyme.[12,102] Catalysis is also facilitated by ionization of
the phenolic moiety of the substrate as induced by
hydrogen bonding to Tyr108, Tyr503, and Arg504
(Figure 3). Another key residue is Asp170, which is
located close to the N5-atom of the flavin and the
reactive methylene group of the substrate. With vanillyl
alcohol, eugenol, and 4-(methoxymethyl)phenol as
substrates, the conserved mutant D170E is up to 100-
fold less active than wild-type VAO whereas with other
Asp170 variants a more than 1,000-fold decrease in
enzyme activity is observed.[103] As no structural changes
were found in the mutant enzymes, this indicates that
Asp170 is crucial for efficient redox catalysis.
Interestingly, substitution of Asp170 by Ser or Glu
strongly influences the hydroxylation efficiency of VAO
with 4-alkylphenols.[104] Whereas theD170A andD170S
mutants favor the hydration of the p-quinone methide
intermediate, theD170Emutant favors the formation of
alkenes. This suggests that the efficiency of hydroxyla-
tion of 4-alkylphenols is regulated by the bulkiness of
the side-chain of residue 170 and not by its ionic
character.
Studies from site-directed double mutants revealed
that the stereochemistry of VAO with short-chain 4-
alkylphenols is also related to the function ofAsp170.[105]
D170A and D170S preferentially hydroxylate 4-ethyl-
phenol to the (R)-enantiomer of 1-(4-hydroxyphen-
yl)ethanol. However, when the acidic residue is relo-
cated to the other face of the substrate binding pocket
(D170A/T457E and D170S/T457E variants), the en-
zyme exhibits an inverted stereoselectivity with 4-
ethylphenol. This high preference for the (S)-enantiom-
er is likely explained by theGlu457 activated attack of a
water molecule from the opposite face of the substrate.
5 Conclusion
Flavoprotein monooxygenases and oxidases are useful
enzymes for the selective introduction of oxygen atoms
in phenolic compounds. Flavoprotein monooxygenases
work optimally around pH 8 whereas VAO is most
active near pH 10. Flavoprotein aromatic hydroxylases
have an unique regiochemistry, allowing the synthesis of
a wide range of catechols and hydroquinones. Most
flavoprotein aromatic hydroxylases have a narrow
substrate specificity and can only be used for the
synthesis of a selected range of products. The substrate
specificity of PHBH can be broadened by site-directed
mutagenesis, but only to a limited extent. Some
flavoprotein aromatic hydroxylases like, e.g., 4-hydroxy-
benzoate 1-hydroxylase and HbpA, have a relaxed
substrate specificity, allowing the synthesis of a range of
ring-substituted hydroquinones and catechols. Directed
evolution has proven to be an attractive method for the
improvement of the efficiency of substrate hydroxyla-
tion of HbpA and for the introduction of new activities.
Two-component flavin-dependent monooxygenases
represent a newly recognized family of oxidative
enzymes and their biocatalytic performance is unex-
plored. It is anticipated that studies from structural and
functional genomics[106] will allow a more thorough
characterization of this class of monooxygenases and
provide future possibilities for synthetic applications.
BVMOs are extremely useful for the synthesis of
esters and lactones and for asymmetric oxidations.
HAPMO is the first described BVMO which is active
with phenolic compounds. The scope of reactions of
HAPMO has not yet been fully explored but it is clear
that this enzyme converts a wide range of acetophe-
nones into the corresponding phenyl acetates.
Flavoprotein oxidases such as VAO are capable of
introducing side-chain modifications in p-substituted
phenols. This is useful for the synthesis of flavors and
fragrances and for the production of pure enantiomers.
Studies from site-directed mutants have demonstrated
that the stereoselectivity of VAO can be inverted by
rational redesign.
Insight into the structure,mechanismandbiochemical
properties of oxidative flavoenzymes is of great help to
select for biocatalysts with a high degree of chemo-,
regio-, and stereoselectivity. In view of the need of
expensive cofactors, it is expected that NAD(P)H-
dependent flavoproteinmonooxygenases will bemainly
used in whole cell systems.[70,88,107±110] Structure-function
relationship studies on PHBH andHAPMO have given
Figure 3. Schematic representation of the active site of the
enzyme-isoeugenol complex of vanillyl-alcohol oxidase from
Penicillium simplicissimum.[101] The isoalloxazine ring of
FAD is black, the inhibitor is gray and the protein residues
are white. Asp170 is positioned at 0.35 nm from flavin N5 and
the C-atom of isoeugenol.
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some insight why these enzymes are strictly dependent
on NADPH. Such studies are not only useful for the
redesign of the coenzyme specificity but will also teach
us more about the evolutionary relationship of flavoen-
zymes.
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